Topic: Disease State Mgt / Drug Therapy

This program equips pharmacists with the knowledge and tools to support patients in preventing and managing common travel-related health conditions. Topics include vaccine recommendations, malaria prophylaxis, rabies pre-exposure considerations, and treatment strategies for illnesses such as traveler’s diarrhea, typhoid, and cholera. Non-infectious issues like motion sickness, jet lag, and altitude illness are also addressed, with emphasis on practical counseling strategies. Pharmacists will gain confidence in educating travelers, optimizing medication use, and promoting safe international travel.

This unique panel style conversation hosts poison control pharmacy specialists to explore the critical role pharmacy professionals play in preventing pediatric poisonings. Designed for pharmacists and pharmacy technicians, the session will examine common risk factors and underlying reasons why poisonings occur in children, highlight evidence-based strategies health care professionals can use to reduce these risks, and outline practical, pharmacy-specific actions to raise awareness within the community. Attendees will leave feeling informed, confident, and empowered to incorporate clear, preventative messaging into everyday patient interactions and community outreach efforts.

So, you have completed your course requirements and earned your certification to perform Medication Therapy Management (MTM). Now what?

This course will offer practical, case-based learning focused on the most essential, relevant information needed by pharmacists to complete comprehensive medication reviews (CMRs). This program will feature clinical vignettes, the incorporation of the latest practice guidelines and therapeutic recommendations, the identification of clinically relevant drug interactions, and the review of appropriate monitoring parameters. Given the limited time and medical information available during a typical MTM session, clinical pearls and common-sense approaches to dispel misinformation and promote adherence (and/or deprescribing) will be provided as well.

This program provides an evidence-based overview of outpatient management strategies for alcohol use disorder (AUD). Participants will learn to assess withdrawal severity using validated tools such as CIWA-Ar, select appropriate pharmacologic agents for acute withdrawal, and apply guideline-recommended therapies for long-term relapse prevention. The course reviews FDA-approved treatments including naltrexone, acamprosate, and disulfiram, along with emerging options such as topiramate. Practical considerations for medication selection, monitoring, and patient-centered care will also be discussed to support pharmacists in optimizing outcomes for patients with AUD.